PIC Signs Exclusive License and Distribution Agreement with Orbit Lifescience for Evarise®

Amman, 6/5/2015 - PIC has entered into an exclusive license and distribution agreement with Orbit Lifescience Pvt. Ltd. (Orbit), under which Orbit grants PIC the exclusive license to market and sell Orbit’s Evarise® in the MENA region. Evarise® is a topical treatment for Female Sexual Arousal Disorder primed to improve cognitive and sexual health in the region.

PIC Acquires Madinet Al Dawaa in Saudi Arabia

Jeddah, 6/7/2015 - PIC announced today the acquisition of Madinet Al Dawaa, a pharmaceutical manufacturing company based in Jeddah, Saudi Arabia.
“This acquisition represents a significant milestone as it considerably strengthens our presence in Saudi Arabia, the largest and most attractive pharmaceutical market in MENA,” noted Hocine Sidi-Said, Chief Executive Officer of PIC. “In addition, it reinforces our commitment to aggressively expand across the MENA region through both organic and inorganic means. Lastly, it allows us to expand our cephalosporin antibiotics manufacturing capacities in both oral solids and injectables.”

PIC Further Enforces Ethical Approach

Amman, 15/12/2015 - PIC has further enforced its ethical approach in business conduct. An updated compliance policy has been initiated at PIC, which feeds into the company’s strategy to remain a trusted biopharmaceutical company in the emerging markets, while stressing on its commitment to provide healthcare services of the highest ethical standards.